ONWARD’s ARC-EX transcutaneous spinal cord stimulation system has received US FDA market authorization. Research on the ARC-EX was advanced in the lab of CNT co-director Chet Moritz. Chet also spoke with Good Morning America about the device.
FDA Market Authorization for ARC-EX